Floatz logo

Therapeutic Asset Ratings

6,538 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Obinutuzumab
Richter's Syndrome
Christine RyanP2BB (71)
Pembrolizumab
Estrogen Receptor Negative
Massachusetts General HospitalP2BB (71)
Pembrolizumab
Progesterone Receptor Negative
Massachusetts General HospitalP2BB (71)
Atezolizumab
Advanced Unresectable or Metastatic Solid Malignancy
UNC Lineberger Comprehensive Cancer CenterP2/3BB (71)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Childhood Chronic Myelogenous Leukemia
Diane GeorgeP2/3BB (71)
Atezolizumab
Stage IV Lung Cancer AJCC v8
University of WashingtonP4BB (70)
Cetuximab
Metastatic Colorectal Cancer
Shanghai Henlius BiotechP4BB (70)
Crizanlizumab
Sickle Cell Disease
Novartis PharmaceuticalsP4BB (70)
Donanemab
Alzheimer Disease
Michael Rafii, MD, PhDP4BB (70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer CenterP4BB (70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Follicular Lymphoma
Sun Yat-sen UniversityP4BB (70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
HIV Infections
UNC Lineberger Comprehensive Cancer CenterP4BB (70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoma
City of Hope Medical CenterP4BB (70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mantle Cell Lymphoma
City of Hope Medical CenterP4BB (70)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY
Psoriasis
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP4BB (70)
Nivolumab
Metastatic Melanoma
Bristol-Myers SquibbP4BB (70)
TRASTUZUMAB
HER2-positive Breast Cancer
SWOG Cancer Research NetworkP4BB (70)
Blinatumomab
Precursor B-Cell Acute Lymphoblastic Leukemia
AmgenP3BB (70)
Cetuximab
Stage IV Colon Cancer
Merck Sharp & Dohme LLCP3BB (70)
Denosumab
Breast Cancer Female NOS
Washington University School of MedicineP3BB (70)
Durvalumab
Locally Advanced Urothelial Carcinoma
Alliance for Clinical Trials in OncologyP3BB (70)
Girentuximab
Kidney Cancer
Memorial Sloan Kettering Cancer CenterP3BB (70)
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 ?1-chain), disulfide with human-Mus musculus monoclonal JMT101 ?-chain, dimer
Local Advanced or Metastatic NSCLC
Shanghai JMT-Bio Inc.P3BB (70)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Stage IV Breast Cancer
SWOG Cancer Research NetworkP3BB (70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Aggressive B-Cell Non-Hodgkin Lymphoma
Shanghai EpimAb Biotherapeutics Co., Ltd.P3BB (70)
Showing 51 to 75 of 6,538 assets
PreviousPage 3 of 262Next